Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.900 | limited | 0.865 | 4 | 0 | 2001 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.700 | None | 0.895 | 14 | 0 | 1992 | 2019 | ||||||||
|
reelin | 0.515 | 0.731 | 1.00 |
|
disease | 0.700 | None | 0.909 | 7 | 0 | 1998 | 2020 | ||||||||
|
cholinergic receptor nicotinic alpha 7 subunit | 0.532 | 0.654 | 4.2E-04 |
|
disease | 0.700 | None | 0.750 | 6 | 0 | 1998 | 2019 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
disease | 0.700 | None | 0.972 | 5 | 0 | 2000 | 2020 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
disease | 0.700 | None | 0.964 | 4 | 0 | 1995 | 2019 | ||||||||
|
serine racemase | 0.617 | 0.692 | 5.8E-03 |
|
disease | 0.700 | None | 0.750 | 2 | 0 | 2005 | 2019 | ||||||||
|
neurexin 1 | 0.581 | 0.692 | 1.00 |
|
disease | 0.700 | None | 0.932 | 1 | 0 | 2008 | 2019 | ||||||||
|
reticulon 4 receptor | 0.595 | 0.692 | 0.96 |
|
disease | 0.670 | None | 0.857 | 3 | 0 | 2004 | 2017 | ||||||||
|
protein phosphatase 3 regulatory subunit B, alpha | 0.682 | 0.538 | 0.41 |
|
disease | 0.630 | None | 1.000 | 1 | 0 | 2003 | 2018 | ||||||||
|
DISC1 scaffold protein | 0.548 | 0.769 | 1.7E-06 |
|
disease | 0.600 | None | 0.947 | 23 | 0 | 2001 | 2020 | ||||||||
|
dystrobrevin binding protein 1 | 0.588 | 0.615 | 6.8E-06 |
|
disease | 0.600 | None | 0.948 | 21 | 0 | 2002 | 2019 | ||||||||
|
glycogen synthase kinase 3 beta | 0.430 | 0.846 | 0.96 |
|
disease | 0.600 | None | 0.880 | 6 | 0 | 2003 | 2020 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.600 | None | 0.780 | 4 | 0 | 1995 | 2019 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.600 | None | 0.951 | 4 | 0 | 2000 | 2019 | ||||||||
|
protein phosphatase 1 regulatory inhibitor subunit 1B | 0.617 | 0.500 | 0.24 |
|
disease | 0.600 | None | 1.000 | 3 | 0 | 2006 | 2019 | ||||||||
|
nuclear receptor subfamily 4 group A member 2 | 0.529 | 0.846 | 1.00 |
|
disease | 0.600 | None | 0.800 | 3 | 0 | 1999 | 2020 | ||||||||
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.964 | 3 | 0 | 1993 | 2020 | ||||||||
|
kynurenine 3-monooxygenase | 0.674 | 0.615 | 4.8E-05 |
|
disease | 0.600 | None | 0.800 | 1 | 0 | 2006 | 2018 | ||||||||
|
myelin basic protein | 0.510 | 0.885 | 0.28 |
|
disease | 0.580 | None | 0.750 | 2 | 0 | 2006 | 2019 | ||||||||
|
complexin 2 | 0.736 | 0.231 | 0.53 |
|
disease | 0.580 | None | 1.000 | 1 | 0 | 1998 | 2015 | ||||||||
|
microtubule associated protein 6 | 0.578 | 0.769 | 0.40 |
|
disease | 0.570 | None | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.550 | None | 0.500 | 2 | 0 | 2004 | 2012 | ||||||||
|
leucine rich repeat transmembrane neuronal 1 | 0.931 | 0.038 | 0.59 |
|
disease | 0.540 | None | 1.000 | 1 | 0 | 2007 | 2014 | ||||||||
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta | 0.743 | 0.269 | 0.78 |
|
disease | 0.540 | None | 0.800 | 1 | 0 | 1999 | 2009 |